|By PR Newswire||
|March 20, 2014 03:15 PM EDT||
DALLAS, March 20, 2014 /PRNewswire-iReach/ -- RnRMarketResearch.com adds "Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast – Worldwide" to its that says China has the highest number of self-monitoring blood glucose device users but United States has highest number of test strips market share.
Blood glucose monitoring devices market is very lucrative business with enormous future potential. Self-monitoring blood glucose market is primarily dependent on number of diabetic patients. So with the growth in diabetic patients blood glucose monitoring devices market is set to grow many folds. By the end of 2013 there was 382 Million people suffering from diabetes and this figure is expect to rise further to 592 Million by 2035.
For the year 2013 Self-monitoring blood glucose (SMBG) users has grown more than 50% from the number of users in 2007. China has the highest number of self-monitoring blood glucose device users but United States has highest number of test strips market share. Although self-monitoring blood glucose devices market is expected to grow with single digit CAGR, but its market is in double digit Billion US$. United States controls the highest market share in the self-monitoring blood glucose (SMBG) market worldwide. 4 companies Roche Diagnostic, LifeScan Inc., Bayer HealthCare and Abbott Laboratories together controls nearly 50% market share of self-monitoring blood glucose devices.
Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=157416 .
This report analyzes the worldwide markets for, blood glucose test strips market, blood glucose lancet market and blood glucose meter market. This report studies separate comprehensive analytics for the 15 countries: United States, European Countries (United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden and Switzerland), BRIC countries (Brazil, Russia, India, China), Australia and Kuwait. Annual estimates and forecast are provided for the period of 2014 through 2020. A six year historic analysis is also provided for these markets. This 265 page report with 257 Figures and 12 Tables provides a complete analysis of top 15 countries of worldwide self-monitoring blood glucose (SMBG) market. All the 15 countries in the report have been studied from 7 viewpoints.
- Countries Diabetes Population Scenario and Future Forecast
- Countries Type 1 and Type 2 Diabetes Scenario and Future Forecast
- Countries Self-Monitoring Blood Glucose (SMBG) devices Users and Future Forecast
- Countries Self-Monitoring Blood Glucose devices (SMBG) Market and Future Forecast
- Countries Blood Glucose Test Strips Market and Future Forecast
- Countries Blood Glucose Lancet Market and Future Forecast
- Countries Blood Glucose Meter and Future Forecast
Comprehensive Table of Contents and more for the report "Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast – Worldwide" is available at http://www.rnrmarketresearch.com/blood-glucose-device-smbg-test-strips-lancet-meter-market-forecast-worldwide-market-report.html .
Top 15 Countries is Covered in this Report
1. United States
2. United Kingdom
4 Companies Revenue (Sales) from self-monitoring blood glucose (SMBG) devices have been analyzed in this report.
- Roche Diagnostic
- LifeScan Inc.,
- Bayer HealthCare
- Abbott Laboratories
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
Other newly published research reports available with us for the Diabetes Device markets include
The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. It also reviews the competitive landscape and gives detailed analysis of each segment's pipeline products, as well as details of important M&A deals.
The global market for diabetes devices was estimated to be worth US$ 12.2 billion in 2012. And although this market was in decline due to intense competition and low reimbursement levels, as well as being traditionally dominated by 6 major manufacturers, good opportunities are growing more apparent for companies with unique diabetes devices or that compete in yet to be established markets.
Media Contact: Priyank Tiwari, RnR Market Research, + 1 888 391 5441, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE RnR Market Research